HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Solitary infantile myofibromatosis of bone. An immunohistochemical and ultrastructural study.

Abstract
A rare case of solitary infantile myofibromatosis of bone in an 11-month-old boy is reported. Radiographically the lesion of parietal bone was round, well-circumscribed, and osteolytic with a sclerotic rim. Histologically the tumor was made up of nodules that were hyalinized or cellular and containing plump, spindle-shaped cells that were intermediate in appearance between fibroblasts and smooth-muscle cells, arranged in short bundles or whorls. Another typical feature was the presence of distended, cleft-shaped vascular spaces around the nodules. The microscopic features of this tumor were consistent with those of infantile myofibromatosis of other sites, such as the skin and deep soft tissue. The tumor cells showed immunoreactivities for vimentin and alpha-smooth muscle actin. Microfilaments with dense bodies were observed in the fibroblast-like tumor cells. In addition, many tumor cells stained for collagen type IV and were covered by incomplete external laminae, indicating infantile myofibromatosis has more advanced smooth-muscle differentiation than conventional fibromatosis.
AuthorsT Hasegawa, T Hirose, K Seki, K Hizawa, J Okada, H Nakanishi
JournalThe American journal of surgical pathology (Am J Surg Pathol) Vol. 17 Issue 3 Pg. 308-13 (Mar 1993) ISSN: 0147-5185 [Print] United States
PMID8434710 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Actins
  • Vimentin
  • Collagen
Topics
  • Actins (analysis)
  • Collagen (analysis)
  • Humans
  • Infant
  • Leiomyoma (chemistry, ultrastructure)
  • Male
  • Muscle, Smooth (chemistry)
  • Parietal Bone (chemistry, ultrastructure)
  • Skull Neoplasms (chemistry, ultrastructure)
  • Vimentin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: